Annual report pursuant to Section 13 and 15(d)

CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS

v3.24.0.1
CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS
12 Months Ended
Dec. 31, 2023
CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS  
CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS

5. CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS

The Company’s cash equivalents and short-term investments are invested in the following (in thousands):

    

December 31, 2023

    

Amortized Cost

    

Unrealized Gains

    

Unrealized Losses

    

Fair Value

Money market funds

$

40,799

$

$

$

40,799

Total cash equivalents

40,799

40,799

Total cash equivalents and short-term investments

$

40,799

$

$

$

40,799

    

December 31, 2022

    

Amortized Cost

    

Unrealized Gains

    

Unrealized Losses

    

Fair Value

Money market funds

$

51,274

$

$

$

51,274

Total cash equivalents

51,274

51,274

Commercial paper

39,781

39,781

Corporate bonds

28,970

(156)

28,814

U.S. Treasury securities

19,896

(78)

19,818

Government bonds

14,846

(102)

14,744

Asset-backed securities

4,000

(2)

3,998

Total short-term investments

107,493

(338)

107,155

Total cash equivalents and short-term investments

$

158,767

$

$

(338)

$

158,429

During the year ended December 31, 2021, the Company made a $20.0 million investment in equity securities of a publicly-traded company. The Company records this investment at fair value within short-term investments, which was $0.6 million and $1.1 million as of the years ended December 31, 2023 and 2022. Prior to the investment, the Company entered into a subscription agreement to purchase the investment, resulting in a subscription agreement liability which was derecognized upon investment. During the years ended December 31, 2023 and 2022, the Company recorded an unrealized loss due to the change in fair value of the equity securities of $0.5 and $6.3 million, respectively, in interest and other (expense) income, net in the consolidated statements of operations.